The Economics of New Health Technologies: Incentives, organization, and financing by Joan Costa-FontThe Economics of New Health Technologies: Incentives, organization, and financing by Joan Costa-Font

The Economics of New Health Technologies: Incentives, organization, and financing

EditorJoan Costa-Font, Christophe Courbage, Alistair McGuire

Paperback | June 15, 2009

Pricing and Purchase Info


Earn 449 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


Technological change in healthcare has led to huge improvements in health services and the health status of populations. It is also pinpointed as the main driver of healthcare expenditure. Although offering remarkable benefits, changes in technology are not free and often entail significantfinancial, as well as physical or social risks. These need to be balanced out in the setting of government regulations, insurance contracts, and individuals' decisions to use and consume certain technologies. With this in mind, this book addresses the following important objectives: to provide adetailed analysis of what technological change is; to identify drivers of innovation in several healthcare areas; to present existing mechanisms and processes for ensuring and valuing efficiency and development in the use of medical technologies; and to analyse the impact of advances in medicaltechnology on health, healthcare expenditure, and health insurance. Each of the seventeen chapters summarizes an important issue concerning the innovation debate and contributes to a better understanding of the role innovation has both at the macro level and at the delivery (meso) and micro level in the healthcare sector. The effectiveness of innovation in improvingpeople's welfare depends on its diffusion and inception by the relevant agents in the health production process, and this book recognizes the multi-faceted contribution of policy makers, regulators, managers, technicians, consumers and patients to this technology change.This book offers the first truly global economic analysis of healthcare technologies, taking the subject beyond simply economic evaluation, and exploring the behavioural aspects, organization and incentives for new technology developments, and the adoption and diffusion of these technologies.
Dr Joan Costa-Font teaches political economy and European social policy at the London School of Economics and Political Science, and has previously taught Economics at the University of Barcelona. Dr Costa-Font is a fellow of CESifo (Munich), the health econometrics and data group (York), FEDEA (Madrid) , IESE Business School and CAEPS...
Title:The Economics of New Health Technologies: Incentives, organization, and financingFormat:PaperbackDimensions:320 pages, 9.21 × 6.14 × 0.02 inPublished:June 15, 2009Publisher:Oxford University PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0199550689

ISBN - 13:9780199550685

Look for similar items by category:


Table of Contents

Part I. Introduction1. Alistair McGuire and Victoria Serra: What do we know about the role of health care technology in driving healthcare expenditure growth?Part II. Innovation, diffusion and technology change2. Davide Consoli, Andrew McMeekin, J. Stan Metcalfe, Andrea Mina and Ronnie Ramlogan: The process of innovation: incentives, behaviour and organization3. Nick Bosanquet: Technology - scientific force or power force?4. Victoria Serra-Sastre and Alistair McGuire: Diffusion of health technologies: evidence from the pharmaceutical sectorPart III. Technological change and health insurance5. Mark Pauly and Adam Isen: Insurance and new health technology6. Peter Zweifel: Technological change and health insurance7. Marin Gemmill, Victoria Serra and Joan Costa-Font: Health insurance and the uptake of new drugs in the United States8. Lilia Filipova and Michael Hoy: Genetic advances and health insurancePart IV. Innovation, social demand and valuation9. Roland Eisen and Yasemin Ilgin: Ageing and pharmaceutical innovation10. Manuel Garcia-Goni and Paul Windrum: New approaches to healthcare innovation: information for chronic patients11. Nicola Pangher: The convergence of nano-, bio- and information technologies in healthcare12. Joshua Graff Zivin, Matthew Neidell, and Lauri Feldman: Treatment uncertainty and irreversibility in medical care: implications for cost-effectiveness analysis13. Adam Oliver and Corinna Sorenson: The limits and challenges to the economic evaluation of health technologiesPart V. Incentives, mechanisms and processes14. Joan Rovira: Intellectual property rights and pharmaceuticals development15. Frank R. Lichtenberg: Home, or nursing home? The effect of medical innovation on the demand for long-term care16. Joan Costa-Font, Caroline Rudisill and Elias Mossialos: Demand for health information on the internet17. Hristina Petkova: Institutional pathways for integrating genetic testing into mainstream healthcare